Sam S. Chang
ORCID: 0000-0003-2066-9468Also affiliated with Vanderbilt University Medical Center
Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Why this DataRank?
An author's DataRank is the sum of the DataRanks of all 2 indexed papers attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.
Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.
Read the full methodology →Papers
Driven by 7 papers. Top paper: “Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin–Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial”.
Stephen A. Boorjian, Mehrdad Alemozaffar, Badrinath R. Konety, Neal D. Shore, Leonard G. Gomella +35 more
Eric Jonasch, Neeraj Agarwal, Clair Beard, Sam Bhayani, Graeme B. Bolger +27 more
Joan P. Breyer, W. Dale Plummer, Sam S. Chang, Michael S. Cookson, Joseph A. Smith +6 more
High-Risk Nonmuscle Invasive Bladder Cancer: Selecting the Appropriate Patient for Timely Cystectomy
Amy N. Luckenbaugh, Sam S. Chang, George E. Koch
Jian Wang, Kristen M. Ogden, Sam S. Chang, Austin N. Kirschner, Woodson Smelser
Jian Wang, Anne Rajkumar-Calkins, Kevin Neuzil, Sam S. Chang, Austin N. Kirschner
Christopher J.D. Wallis, Amy N. Luckenbaugh, Daniel A. Barocas, Sam S. Chang, David F. Penson +3 more